Logo image
Classification of pharmaceutical toxicity by feature analysis
Conference proceeding

Classification of pharmaceutical toxicity by feature analysis

J Quinn, Lit-Hsin Loo, J Armitage, H Cordingley, S Roberts, P.J Bugelski, M Kam and L Hrebien
Proceedings of the IEEE 28th Annual Northeast Bioengineering Conference (IEEE Cat. No.02CH37342), v 2002-
2002

Abstract

Animals Clinical trials Drugs In vivo Liver Measurement standards Pharmaceuticals Proteins Rats Vehicles
The drug discovery process is far from optimal; only 1 in 10 compounds selected for development successfully reach the clinical trial phase. In an attempt to improve the efficiency of this process, we have applied feature analysis techniques to polypeptide spectral data from the liver of rats that have been exposed to various dosages of pharmaceuticals. Our goal is to use these techniques to predict the toxicity of a compound in vivo and help eliminate potentially dangerous pharmaceuticals from advancing past early stages of discovery.

Metrics

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Web of Science research areas
Engineering, Biomedical
Logo image